Eli Lilly and Company

Eli Lilly and Company discovers develops and markets human pharmaceuticals worldwide It offers Basaglar Humalog Humalog Mix 7525 Humalog U100 Humalog U200 Humalog Mix 5050 insulin lispro insulin lispro protamine insulin lispro mix 7525 Humulin Humulin 7030 Humulin N Humulin R and Humulin U500 for diabetes and Jardiance Trajenta and Trulicity for type 2 diabetes The company provides Alimta for nonsmall cell lung cancer NSCLC and malignant pleural mesothelioma Cyramza for metastatic gastric cancer gastroesophageal junction adenocarcinoma metastatic NSCLC metastatic colorectal cancer and hepatocellular carcinoma Erbitux for colorectal cancers and various head and neck cancers Retevmo for metastatic NSCLC medullary thyroid cancer and thyroid cancer Tyvyt for relapsed or refractory classic Hodgkins lymph and nonsquamous NSCLC and Verzenio for HR HER2 metastatic breast cancer node positive and early breast cancer It offers Olumiant for rheumatoid arthritis and Taltz for plaque psoriasis psoriatic arthritis ankylosing spondylitis and nonradiographic axial spondylarthritis The company offers Cymbalta for depressive disorder diabetic peripheral neuropathic pain generalized anxiety disorder fibromyalgia and chronic musculoskeletal pain Emgality for migraine prevention and episodic cluster headache and Zyprexa for schizophrenia bipolar I disorder and bipolar maintenance Its Bamlanivimab and etesevimab and Bebtelovimab for COVID19 Cialis for erectile dysfunction and benign prostatic hyperplasia and Forteo for osteoporosis The company has collaborations with Incyte Corporation Boehringer Ingelheim Pharmaceuticals Inc AbCellera Biologics Inc Junshi Biosciences Regor Therapeutics Group Lycia Therapeutics Inc Kumquat Biosciences Inc Entos Pharmaceuticals Inc and Foghorn Therapeutics Inc Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis Indiana